Becton Dickinson and

Becton Dickinson and

Yahoo Finance • 6 hours ago

BD Names Bridget Bagnato Worldwide President of Peripheral Intervention

FRANKLIN LAKES, N.J., Nov. 4, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Bridget Bagnato has been appointed worldwide president of its Peripheral I... Full story

Yahoo Finance • yesterday

What FT Vest Dividend Aristocrats Target Income (KNG) Bought: C.H. Robinson Leads on Oct. 30

This article first appeared on GuruFocus. FT Vest S&P 500 Dividend Aristocrats Target Income ETF (KNG) reported $317.7 million in gross ETF activity on Friday, Oct. 30, against $3.46 billion in assets. KNG increased 35 positions and decre... Full story

Yahoo Finance • yesterday

What ProShares Dividend Aristocrats (NOBL) Bought: Kimberly-Clark Leads on Friday

This article first appeared on GuruFocus. ProShares S&P 500 Dividend Aristocrats ETF (NOBL) increased 35 positions and trimmed 34 on Friday, Oct. 30, posting a net outflow of $31.2 million. ETF activity totaled $1.40 billion in gross trad... Full story

Yahoo Finance • yesterday

State Street SPDR S&P Dividend ETF (SDY) Sells Accenture and Chevron on Oct. 30

This article first appeared on GuruFocus. State Street SPDR S&P Dividend ETF (SDY) was one of the ETFs selling last Friday, with 110 positions decreased against 45 increased. The $23.87 billion fund recorded $3.76 billion in gross ETF act... Full story

Yahoo Finance • yesterday

ETF Activity: SPY Pulls In $5.73 Billion on Oct. 30

This article first appeared on GuruFocus. ETF activity on Friday was firmly positive, with 373 funds reporting a net estimated inflow of $6.83 billion as 37,063 positions increased against 20,052 that decreased. SPY dominated the picture,... Full story

Yahoo Finance • 12 days ago

What Becton Dickinson Stock's New U.S. Manufacturing Deal Means For Shareholders

Becton Dickinson has seen stronger performance in its high growth segments, supported by ongoing product development, clinical trial progress, and a major U.S. manufacturing agreement that was announced before the scheduled fiscal 2026 fou... Full story

Yahoo Finance • 12 days ago

Becton Dickinson (BDX) Stock Trades Below Fair Value After A 40% Run

Becton Dickinson has delivered a strong share price run over the past year, which puts fresh focus on whether the current US$200.42 level is grounded in the cash it can generate. For anyone looking at the stock today, the central issue is... Full story

Yahoo Finance • 14 days ago

BSX Set to Report Q3 Earnings: Will MedSurg Strength Aid Performance?

Boston Scientific Corporation BSX is slated to report third-quarter 2026 results on Oct. 28, before the market opens. The renowned medical device manufacturer posted earnings per share (EPS) of 86 cents in the last reported quarter, which... Full story

Yahoo Finance • 14 days ago

Ecolab Gears Up to Report Q3 Results: How to Play the Stock?

Ecolab ECL is scheduled to release third-quarter 2026 results on Oct. 27, before the opening bell. In the last reported quarter, the company delivered earnings that surpassed the estimates by 0.48%. ECL's earnings beat estimates in three o... Full story

Yahoo Finance • 22 days ago

Becton Dickinson (BDX) Grew Revenue 5.4% While Earnings Fell 34.3%. Why Did Profit Fall So Much Further?

Becton, Dickinson and Company (NYSE:BDX) closed at $188.89 on October 12. The stock has returned over 21.5% during the last six months, compared to a 21.25% return for the Insider Monkey Billionaire Index and 14% for State Street SPDR S&P... Full story

Yahoo Finance • 24 days ago

Notable healthcare headlines for the week: Novavax, Moderna and Becton Dickinson in focus

Wall Street regained some momentum on Friday, after the AI trade came under pressure on Thursday. The S&P 500 (SP500 [https://seekingalpha.com/symbol/SP500#source=url_first_level%3Amarket-news%7Csection%3Amarket-news%7Csection_asset%3Aful... Full story

Yahoo Finance • 27 days ago

Becton Dickinson (BDX) Posts Strong AGILITY Trial Results, Is The Stock Still Below Fair Value?

Becton Dickinson (BDX) just put fresh clinical data in front of investors. Nine-month results from the AGILITY trial for its Revello Vascular Covered Stent showed the study hit its primary endpoint in iliac artery disease. Recent clinical... Full story

Yahoo Finance • 29 days ago

BD Appoints Ferass Abuzaina as Worldwide President of Surgery

FRANKLIN LAKES, N.J., Oct. 6, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Ferass Abuzaina has been named worldwide president of the Surgery business... Full story

Yahoo Finance • 29 days ago

BD and U.S. Government Launch Landmark Partnership to Expand U.S. Manufacturing and Strengthen America's Healthcare Resilience

Agreement supports significant investments in U.S. manufacturing, strengthens healthcare resilience and increases domestic production of essential medical consumables used in approximately 90% of U.S. hospital visits  FRANKLIN LAKES, N.J.... Full story

Yahoo Finance • last month

Fiscal Stimulus Stocks With Real Exposure to Government Infrastructure Spending

When governments rediscover Keynes and start talking loudly about stimulus, capital does not wait on the sidelines. Policy debate can quickly translate into real money flowing toward projects, contractors and service providers that sit clo... Full story

Yahoo Finance • 2 months ago

BDX Deploys Vmax 160 to Advance Intelligent Pharmacy Automation

Becton, Dickinson and Company BDX, popularly known as BD, recently advanced its pharmacy automation portfolio in the United States with the deployment of BD Vmax 160, its next-generation pharmacy automation robot at Fairview Health Service... Full story

Yahoo Finance • 2 months ago

BAX Raises 2026 Outlook as Strong Q2 Growth Offsets Margin Pressure

Baxter International Inc. BAX raised its 2026 sales and adjusted earnings outlook after second-quarter results exceeded expectations. The update gives investors another data point on the company's early-stage turnaround as operating execut... Full story

Yahoo Finance • 2 months ago

Becton Dickinson (BDX) Becomes Founding Sponsor Of Hazardous Drug Data Consortium

Becton Dickinson (NYSE:BDX) has become a founding sponsor of a new Medicinal Hazard Data Standardization Consortium focused on hazardous drug information. The global initiative aims to create standardized Medicinal Hazard Data Sheets to re... Full story

Yahoo Finance • 2 months ago

Two Recessions Couldn’t Stop These 4 Healthcare Stocks From Raising Dividends

Quick Read JNJ carries a 64-year dividend raise streak backed by $21 billion in FCF; MDT leads the group in yield at 3.16% with 49 consecutive annual increases. Inelastic demand for drugs, diagnostics, and medical devices kept all four st... Full story

Yahoo Finance • 2 months ago

Four Industry Sponsors Commit $100,000 to Launch the Medicinal Hazard Data Standardization Consortium

Funding advances one internationally harmonized hazardous drug list and expanded Medicinal Hazard Data Sheets, as the 84th FIP World Congress convenes in Montréal MONTRÉAL, QC / ACCESS Newswire / August 31, 2026 / Pharmacy Stars, BD (Bect... Full story